申请人:Setoh Masaki
公开号:US20110009421A1
公开(公告)日:2011-01-13
An object of the present invention is to provide an agent for preventing or treating schizophrenia or the like, wherein the compound of the present invention has GPRS2 agonist activity.
[Means] A compound represented by the following formula (I) or salt thereof:
wherein
A represents —(CH
2
)
n
—CO—NR
a
— (n is an integer of 0 to 3) or —NR
a
—CO—,
B represents a hydrogen atom, halogen atom, cyano group, hydroxy group, or the like,
X
1
, X
2
, X
3
, and X
4
represent the same or different —CR
x
═, or —N═,
Y represents —O—, —S—, —S(O)—, —S(O)
2
—, or —NR
y
—,
Z represents a bond, methylene, or ethylene,
Ar
1
represents a five- to ten-membered aromatic ring (except for thiazole) which may be substituted with one or more substituents selected from halogen atoms, optionally halogenated C
1-6
alkyl groups, and the like,
Ar
2
represents a five- to six-membered aromatic ring which may be substituted with one or more substituents selected from halogen atoms, optionally halogenated C
1-6
alkyl groups, and the like, and which may be condensed with an optionally substituted five- to six-membered ring, and
R
a
, R
b
, R
x
, and R
y
represent the same or different hydrogen atom, halogen atoms, or the like].
本发明的目的是提供一种用于预防或治疗精神分裂症等疾病的药剂,其中本发明的化合物具有GPR
S2激动剂活性。[手段]以下式(I)或其盐所表示的化合物:其中A代表—(
CH2)n—CO—NRa—(n为0至3的整数)或—NRa—CO—,B代表
氢原子、卤原子、
氰基、羟基等,X1、X2、X3和X4代表相同或不同的—CRx═或—N═,Y代表—O—、—S—、—S(O)—、—S(O)2—或—NRy—,Z代表键、亚
甲基或
乙烯基,Ar1代表一个五至十元环芳香环(除
噻唑外),可以被一个或多个卤原子、可选卤代C1-6烷基等取代,Ar2代表一个五至六元环芳香环,可以被一个或多个卤原子、可选卤代C1-6烷基等取代,可以与一个可选取代的五至六元环融合,并且Ra、Rb、Rx和Ry代表相同或不同的
氢原子、卤原子等。